Jeena Sikho Lifecare (JSLL) reported impressive financial results for the quarter and half-year.

Revenue from operations hit ₹189.85 Cr, surging 66% YoY and 9% QoQ.

Profit After Tax (PAT) jumped 121% YoY and 15% QoQ to ₹58.78 Cr.

EBITDA margin improved to a strong 48%. Basic EPS stood at ₹4.73. Patient volumes showed robust growth, with IPD up 57% YoY and OPD up 67% YoY.

The company's strategy includes a successful shift towards its higher-margin private business segment.

Three new hospitals launched in the quarter, expanding total operational beds to over 2,220, with 400 more in pipeline.

Recent product launches like Dr. BP Care DS and a new Salesforce partnership for digital transformation are key growth drivers, with six more products planned.

Management is confident in sustained growth, enhanced profitability, and long-term value.